Preload Image
Preload Image
Report Store mobile icon
Global Antidepressants Market Growth 2024-2030

Global Antidepressants Market Growth 2024-2030

2024

Global Antidepressants Market Growth 2024-2030

The global antidepressants market is valued at US$ 14.05 billion in 2024, driven by growing mental health awareness and treatment needs.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global antidepressants market has witnessed significant growth in recent years, driven by the increasing prevalence of mental health disorders, greater awareness about depression, and improved access to healthcare. Depression, one of the most common mental health conditions worldwide, affects millions of people, with a rising number of diagnoses reported across various regions. The market for antidepressants has expanded as a result of this growing demand for treatment options, as well as the increasing recognition of the importance of mental health in overall well-being. Factors such as the growing stress levels in modern society, changing lifestyles, and the impact of the COVID-19 pandemic on mental health have contributed to an increase in the number of individuals seeking antidepressant medications. In addition, the rising awareness about mental health conditions, as well as the destigmatization of seeking professional help for depression and anxiety, has further accelerated the demand for antidepressants. Pharmaceutical companies have been focusing on developing more effective and targeted treatments to address a variety of mood disorders, including major depressive disorder, generalized anxiety disorder, and other mood-related conditions. The availability of different classes of antidepressant drugs, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and newer options like atypical antidepressants, has provided healthcare providers with a broad range of therapeutic options for patients. As treatment paradigms evolve and a growing emphasis is placed on personalized medicine, the antidepressants market is expected to continue expanding, with new drug innovations and improved patient outcomes driving market growth.

According to Publisher, global Antidepressants market size was valued at US$ 14050 million in 2024. With growing demand in downstream market, the Antidepressants is forecast to a readjusted size of US$ 17780 million by 2030 with a CAGR of 3.4% during review period. North America dominates the global antidepressants market, accounting for a significant share of the market revenue. The region’s advanced healthcare infrastructure, higher levels of mental health awareness, and strong research and development activities in the pharmaceutical industry have contributed to the widespread adoption of antidepressant treatments. The United States, in particular, represents the largest market in North America, with a high number of people seeking treatment for depression and related mood disorders. The availability of a broad range of antidepressant medications and the increasing recognition of the need for mental health care are key drivers behind the strong demand in the region. The European market also represents a substantial share of the global antidepressants market, driven by an increasing focus on mental health, government initiatives to improve mental health care access, and a rising number of individuals diagnosed with depressive disorders. Countries such as Germany, the United Kingdom, and France have seen rising demand for antidepressants due to both the growing prevalence of mental health conditions and increasing efforts to improve access to effective treatments. The Asia Pacific region is expected to witness the fastest growth in the antidepressants market, driven by increasing awareness of mental health issues, changing attitudes towards depression treatment, and growing healthcare access in emerging markets such as China, India, and Japan. The increasing pressure of urbanization, work-related stress, and social changes are contributing to higher rates of depression in these countries, spurring the demand for antidepressant medications. As governments and healthcare systems in the region invest in mental health initiatives, the antidepressants market is expected to expand rapidly, with both established players and new entrants catering to the rising demand.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The global antidepressants market can be segmented by drug class, with major categories including selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), and others. Among these, SSRIs hold the largest market share due to their effectiveness in treating depression, lower risk of side effects, and safer profile compared to other classes of antidepressants. SSRIs work by increasing serotonin levels in the brain, which helps regulate mood and reduce symptoms of depression. Common SSRIs include fluoxetine, sertraline, and escitalopram, which have become widely prescribed for patients with various mood disorders. SNRIs, which work by increasing both serotonin and norepinephrine levels, are also gaining popularity in the antidepressants market. Medications such as venlafaxine and duloxetine have been approved for the treatment of major depressive disorder and generalized anxiety disorder, making them essential components of antidepressant therapy. Tricyclic antidepressants (TCAs) were once the mainstay of depression treatment but have largely been replaced by SSRIs and SNRIs due to their more favorable side effect profiles. However, TCAs are still used in certain cases, particularly when patients do not respond to newer medications. Monoamine oxidase inhibitors (MAOIs) are also used for depression treatment but are typically reserved for patients who have not responded to other medications due to their potential for serious side effects and dietary restrictions. The segment of atypical antidepressants includes drugs such as bupropion and mirtazapine, which are used in cases where patients do not respond to traditional antidepressants. As research continues and new drugs are developed, additional drug classes may emerge to address specific patient needs, further diversifying the antidepressants market.
The antidepressants market can also be segmented by application, with key areas including major depressive disorder (MDD), generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and others.

Major depressive disorder remains the largest application segment, as it is one of the most common mood disorders worldwide, with millions of people affected by it. Antidepressant medications are the primary treatment for MDD, helping to alleviate symptoms such as persistent sadness, fatigue, and loss of interest in activities. As the number of individuals diagnosed with MDD continues to rise globally, particularly in regions with higher stress levels, the demand for antidepressant medications remains strong. Generalized anxiety disorder is another major application area, as many patients with anxiety disorders also experience symptoms of depression. Antidepressants, particularly SSRIs and SNRIs, are often used to treat both anxiety and depressive symptoms in patients. Other conditions such as PTSD and OCD are also significant drivers of the antidepressants market, with patients requiring specific medication regimens to manage symptoms. As awareness of mental health issues continues to grow and the stigma surrounding mental health treatment decreases, there is an increasing recognition of the need for specialized treatments for these disorders. Additionally, the development of personalized treatment strategies, including genetic testing and the identification of specific biomarkers, is expected to further enhance the precision of antidepressant therapies, improving patient outcomes and driving market growth. With ongoing advancements in psychiatric research, the applications of antidepressants are likely to expand, ensuring that the market continues to evolve in response to the growing demand for effective treatments for mood disorders.


Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Antidepressants Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Antidepressants by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Antidepressants by Country/Region, 2019, 2023 & 2030
  • 2.2 Antidepressants Segment by Type
  • 2.2.1 Tricyclic Antidepressants
  • 2.2.2 Selective Serotonin Reuptake Inhibitors
  • 2.2.3 Selective Norepinephrine Reuptake Inhibitors
  • 2.2.4 Monoamine Oxidase Inhibitors
  • 2.2.5 Benzodiazepines
  • 2.2.6 Antipsychotics
  • 2.2.7 Novel Agents
  • 2.3 Antidepressants Sales by Type
  • 2.3.1 Global Antidepressants Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Antidepressants Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Antidepressants Sale Price by Type (2019-2024)
  • 2.4 Antidepressants Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Other
  • 2.5 Antidepressants Sales by Application
  • 2.5.1 Global Antidepressants Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Antidepressants Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Antidepressants Sale Price by Application (2019-2024)
  • 3 Global Antidepressants by Company
  • 3.1 Global Antidepressants Breakdown Data by Company
  • 3.1.1 Global Antidepressants Annual Sales by Company (2019-2024)
  • 3.1.2 Global Antidepressants Sales Market Share by Company (2019-2024)
  • 3.2 Global Antidepressants Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Antidepressants Revenue by Company (2019-2024)
  • 3.2.2 Global Antidepressants Revenue Market Share by Company (2019-2024)
  • 3.3 Global Antidepressants Sale Price by Company
  • 3.4 Key Manufacturers Antidepressants Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Antidepressants Product Location Distribution
  • 3.4.2 Players Antidepressants Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Antidepressants by Geographic Region
  • 4.1 World Historic Antidepressants Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Antidepressants Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Antidepressants Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Antidepressants Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Antidepressants Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Antidepressants Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Antidepressants Sales Growth
  • 4.4 APAC Antidepressants Sales Growth
  • 4.5 Europe Antidepressants Sales Growth
  • 4.6 Middle East & Africa Antidepressants Sales Growth
  • 5 Americas
  • 5.1 Americas Antidepressants Sales by Country
  • 5.1.1 Americas Antidepressants Sales by Country (2019-2024)
  • 5.1.2 Americas Antidepressants Revenue by Country (2019-2024)
  • 5.2 Americas Antidepressants Sales by Type
  • 5.3 Americas Antidepressants Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Antidepressants Sales by Region
  • 6.1.1 APAC Antidepressants Sales by Region (2019-2024)
  • 6.1.2 APAC Antidepressants Revenue by Region (2019-2024)
  • 6.2 APAC Antidepressants Sales by Type
  • 6.3 APAC Antidepressants Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Antidepressants by Country
  • 7.1.1 Europe Antidepressants Sales by Country (2019-2024)
  • 7.1.2 Europe Antidepressants Revenue by Country (2019-2024)
  • 7.2 Europe Antidepressants Sales by Type
  • 7.3 Europe Antidepressants Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Antidepressants by Country
  • 8.1.1 Middle East & Africa Antidepressants Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Antidepressants Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Antidepressants Sales by Type
  • 8.3 Middle East & Africa Antidepressants Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Antidepressants
  • 10.3 Manufacturing Process Analysis of Antidepressants
  • 10.4 Industry Chain Structure of Antidepressants
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Antidepressants Distributors
  • 11.3 Antidepressants Customer
  • 12 World Forecast Review for Antidepressants by Geographic Region
  • 12.1 Global Antidepressants Market Size Forecast by Region
  • 12.1.1 Global Antidepressants Forecast by Region (2025-2030)
  • 12.1.2 Global Antidepressants Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Antidepressants Forecast by Type
  • 12.7 Global Antidepressants Forecast by Application
  • 13 Key Players Analysis
  • 13.1 H Lundbeck
  • 13.1.1 H Lundbeck Company Information
  • 13.1.2 H Lundbeck Antidepressants Product Portfolios and Specifications
  • 13.1.3 H Lundbeck Antidepressants Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 H Lundbeck Main Business Overview
  • 13.1.5 H Lundbeck Latest Developments
  • 13.2 Astrazeneca
  • 13.2.1 Astrazeneca Company Information
  • 13.2.2 Astrazeneca Antidepressants Product Portfolios and Specifications
  • 13.2.3 Astrazeneca Antidepressants Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Astrazeneca Main Business Overview
  • 13.2.5 Astrazeneca Latest Developments
  • 13.3 Eli Lilly and Company
  • 13.3.1 Eli Lilly and Company Company Information
  • 13.3.2 Eli Lilly and Company Antidepressants Product Portfolios and Specifications
  • 13.3.3 Eli Lilly and Company Antidepressants Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Eli Lilly and Company Main Business Overview
  • 13.3.5 Eli Lilly and Company Latest Developments
  • 13.4 Sun Pharmaceuticals
  • 13.4.1 Sun Pharmaceuticals Company Information
  • 13.4.2 Sun Pharmaceuticals Antidepressants Product Portfolios and Specifications
  • 13.4.3 Sun Pharmaceuticals Antidepressants Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Sun Pharmaceuticals Main Business Overview
  • 13.4.5 Sun Pharmaceuticals Latest Developments
  • 13.5 Pfizer Inc.
  • 13.5.1 Pfizer Inc. Company Information
  • 13.5.2 Pfizer Inc. Antidepressants Product Portfolios and Specifications
  • 13.5.3 Pfizer Inc. Antidepressants Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Pfizer Inc. Main Business Overview
  • 13.5.5 Pfizer Inc. Latest Developments
  • 13.6 GlaxoSmithKline
  • 13.6.1 GlaxoSmithKline Company Information
  • 13.6.2 GlaxoSmithKline Antidepressants Product Portfolios and Specifications
  • 13.6.3 GlaxoSmithKline Antidepressants Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 GlaxoSmithKline Main Business Overview
  • 13.6.5 GlaxoSmithKline Latest Developments
  • 13.7 Bristol-Myers Squibb Company
  • 13.7.1 Bristol-Myers Squibb Company Company Information
  • 13.7.2 Bristol-Myers Squibb Company Antidepressants Product Portfolios and Specifications
  • 13.7.3 Bristol-Myers Squibb Company Antidepressants Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Bristol-Myers Squibb Company Main Business Overview
  • 13.7.5 Bristol-Myers Squibb Company Latest Developments
  • 13.8 Johnson & Johnson
  • 13.8.1 Johnson & Johnson Company Information
  • 13.8.2 Johnson & Johnson Antidepressants Product Portfolios and Specifications
  • 13.8.3 Johnson & Johnson Antidepressants Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 Johnson & Johnson Main Business Overview
  • 13.8.5 Johnson & Johnson Latest Developments
  • 13.9 Merck
  • 13.9.1 Merck Company Information
  • 13.9.2 Merck Antidepressants Product Portfolios and Specifications
  • 13.9.3 Merck Antidepressants Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 Merck Main Business Overview
  • 13.9.5 Merck Latest Developments
  • 13.10 Sanofi
  • 13.10.1 Sanofi Company Information
  • 13.10.2 Sanofi Antidepressants Product Portfolios and Specifications
  • 13.10.3 Sanofi Antidepressants Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 Sanofi Main Business Overview
  • 13.10.5 Sanofi Latest Developments
  • 14 Research Findings and Conclusion


Table 1. Antidepressants Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Antidepressants Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Tricyclic Antidepressants
Table 4. Major Players of Selective Serotonin Reuptake Inhibitors
Table 5. Major Players of Selective Norepinephrine Reuptake Inhibitors
Table 6. Major Players of Monoamine Oxidase Inhibitors
Table 7. Major Players of Benzodiazepines
Table 8. Major Players of Antipsychotics
Table 9. Major Players of Novel Agents
Table 10. Global Antidepressants Sales by Type (2019-2024) & (K Units)
Table 11. Global Antidepressants Sales Market Share by Type (2019-2024)
Table 12. Global Antidepressants Revenue by Type (2019-2024) & ($ million)
Table 13. Global Antidepressants Revenue Market Share by Type (2019-2024)
Table 14. Global Antidepressants Sale Price by Type (2019-2024) & (USD/Unit)
Table 15. Global Antidepressants Sales by Application (2019-2024) & (K Units)
Table 16. Global Antidepressants Sales Market Share by Application (2019-2024)
Table 17. Global Antidepressants Revenue by Application (2019-2024)
Table 18. Global Antidepressants Revenue Market Share by Application (2019-2024)
Table 19. Global Antidepressants Sale Price by Application (2019-2024) & (USD/Unit)
Table 20. Global Antidepressants Sales by Company (2019-2024) & (K Units)
Table 21. Global Antidepressants Sales Market Share by Company (2019-2024)
Table 22. Global Antidepressants Revenue by Company (2019-2024) ($ Millions)
Table 23. Global Antidepressants Revenue Market Share by Company (2019-2024)
Table 24. Global Antidepressants Sale Price by Company (2019-2024) & (USD/Unit)
Table 25. Key Manufacturers Antidepressants Producing Area Distribution and Sales Area
Table 26. Players Antidepressants Products Offered
Table 27. Antidepressants Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Antidepressants Sales by Geographic Region (2019-2024) & (K Units)
Table 31. Global Antidepressants Sales Market Share Geographic Region (2019-2024)
Table 32. Global Antidepressants Revenue by Geographic Region (2019-2024) & ($ millions)
Table 33. Global Antidepressants Revenue Market Share by Geographic Region (2019-2024)
Table 34. Global Antidepressants Sales by Country/Region (2019-2024) & (K Units)
Table 35. Global Antidepressants Sales Market Share by Country/Region (2019-2024)
Table 36. Global Antidepressants Revenue by Country/Region (2019-2024) & ($ millions)
Table 37. Global Antidepressants Revenue Market Share by Country/Region (2019-2024)
Table 38. Americas Antidepressants Sales by Country (2019-2024) & (K Units)
Table 39. Americas Antidepressants Sales Market Share by Country (2019-2024)
Table 40. Americas Antidepressants Revenue by Country (2019-2024) & ($ Millions)
Table 41. Americas Antidepressants Revenue Market Share by Country (2019-2024)
Table 42. Americas Antidepressants Sales by Type (2019-2024) & (K Units)
Table 43. Americas Antidepressants Sales by Application (2019-2024) & (K Units)
Table 44. APAC Antidepressants Sales by Region (2019-2024) & (K Units)
Table 45. APAC Antidepressants Sales Market Share by Region (2019-2024)
Table 46. APAC Antidepressants Revenue by Region (2019-2024) & ($ Millions)
Table 47. APAC Antidepressants Revenue Market Share by Region (2019-2024)
Table 48. APAC Antidepressants Sales by Type (2019-2024) & (K Units)
Table 49. APAC Antidepressants Sales by Application (2019-2024) & (K Units)
Table 50. Europe Antidepressants Sales by Country (2019-2024) & (K Units)
Table 51. Europe Antidepressants Sales Market Share by Country (2019-2024)
Table 52. Europe Antidepressants Revenue by Country (2019-2024) & ($ Millions)
Table 53. Europe Antidepressants Revenue Market Share by Country (2019-2024)
Table 54. Europe Antidepressants Sales by Type (2019-2024) & (K Units)
Table 55. Europe Antidepressants Sales by Application (2019-2024) & (K Units)
Table 56. Middle East & Africa Antidepressants Sales by Country (2019-2024) & (K Units)
Table 57. Middle East & Africa Antidepressants Sales Market Share by Country (2019-2024)
Table 58. Middle East & Africa Antidepressants Revenue by Country (2019-2024) & ($ Millions)
Table 59. Middle East & Africa Antidepressants Revenue Market Share by Country (2019-2024)
Table 60. Middle East & Africa Antidepressants Sales by Type (2019-2024) & (K Units)
Table 61. Middle East & Africa Antidepressants Sales by Application (2019-2024) & (K Units)
Table 62. Key Market Drivers & Growth Opportunities of Antidepressants
Table 63. Key Market Challenges & Risks of Antidepressants
Table 64. Key Industry Trends of Antidepressants
Table 65. Antidepressants Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Antidepressants Distributors List
Table 68. Antidepressants Customer List
Table 69. Global Antidepressants Sales Forecast by Region (2025-2030) & (K Units)
Table 70. Global Antidepressants Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Americas Antidepressants Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Americas Antidepressants Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. APAC Antidepressants Sales Forecast by Region (2025-2030) & (K Units)
Table 74. APAC Antidepressants Revenue Forecast by Region (2025-2030) & ($ millions)
Table 75. Europe Antidepressants Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Antidepressants Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Middle East & Africa Antidepressants Sales Forecast by Country (2025-2030) & (K Units)
Table 78. Middle East & Africa Antidepressants Revenue Forecast by Country (2025-2030) & ($ millions)
Table 79. Global Antidepressants Sales Forecast by Type (2025-2030) & (K Units)
Table 80. Global Antidepressants Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 81. Global Antidepressants Sales Forecast by Application (2025-2030) & (K Units)
Table 82. Global Antidepressants Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 83. H Lundbeck Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 84. H Lundbeck Antidepressants Product Portfolios and Specifications
Table 85. H Lundbeck Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. H Lundbeck Main Business
Table 87. H Lundbeck Latest Developments
Table 88. Astrazeneca Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 89. Astrazeneca Antidepressants Product Portfolios and Specifications
Table 90. Astrazeneca Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Astrazeneca Main Business
Table 92. Astrazeneca Latest Developments
Table 93. Eli Lilly and Company Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 94. Eli Lilly and Company Antidepressants Product Portfolios and Specifications
Table 95. Eli Lilly and Company Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Eli Lilly and Company Main Business
Table 97. Eli Lilly and Company Latest Developments
Table 98. Sun Pharmaceuticals Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 99. Sun Pharmaceuticals Antidepressants Product Portfolios and Specifications
Table 100. Sun Pharmaceuticals Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Sun Pharmaceuticals Main Business
Table 102. Sun Pharmaceuticals Latest Developments
Table 103. Pfizer Inc. Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Inc. Antidepressants Product Portfolios and Specifications
Table 105. Pfizer Inc. Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Pfizer Inc. Main Business
Table 107. Pfizer Inc. Latest Developments
Table 108. GlaxoSmithKline Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 109. GlaxoSmithKline Antidepressants Product Portfolios and Specifications
Table 110. GlaxoSmithKline Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. GlaxoSmithKline Main Business
Table 112. GlaxoSmithKline Latest Developments
Table 113. Bristol-Myers Squibb Company Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 114. Bristol-Myers Squibb Company Antidepressants Product Portfolios and Specifications
Table 115. Bristol-Myers Squibb Company Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Bristol-Myers Squibb Company Main Business
Table 117. Bristol-Myers Squibb Company Latest Developments
Table 118. Johnson & Johnson Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 119. Johnson & Johnson Antidepressants Product Portfolios and Specifications
Table 120. Johnson & Johnson Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Johnson & Johnson Main Business
Table 122. Johnson & Johnson Latest Developments
Table 123. Merck Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 124. Merck Antidepressants Product Portfolios and Specifications
Table 125. Merck Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Merck Main Business
Table 127. Merck Latest Developments
Table 128. Sanofi Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 129. Sanofi Antidepressants Product Portfolios and Specifications
Table 130. Sanofi Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. Sanofi Main Business
Table 132. Sanofi Latest Developments
List of


Figure 1. Picture of Antidepressants
Figure 2. Antidepressants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antidepressants Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Antidepressants Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Antidepressants Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Tricyclic Antidepressants
Figure 10. Product Picture of Selective Serotonin Reuptake Inhibitors
Figure 11. Product Picture of Selective Norepinephrine Reuptake Inhibitors
Figure 12. Product Picture of Monoamine Oxidase Inhibitors
Figure 13. Product Picture of Benzodiazepines
Figure 14. Product Picture of Antipsychotics
Figure 15. Product Picture of Novel Agents
Figure 16. Global Antidepressants Sales Market Share by Type in 2023
Figure 17. Global Antidepressants Revenue Market Share by Type (2019-2024)
Figure 18. Antidepressants Consumed in Hospitals
Figure 19. Global Antidepressants Market: Hospitals (2019-2024) & (K Units)
Figure 20. Antidepressants Consumed in Clinics
Figure 21. Global Antidepressants Market: Clinics (2019-2024) & (K Units)
Figure 22. Antidepressants Consumed in Other
Figure 23. Global Antidepressants Market: Other (2019-2024) & (K Units)
Figure 24. Global Antidepressants Sales Market Share by Application (2023)
Figure 25. Global Antidepressants Revenue Market Share by Application in 2023
Figure 26. Antidepressants Sales Market by Company in 2023 (K Units)
Figure 27. Global Antidepressants Sales Market Share by Company in 2023
Figure 28. Antidepressants Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Antidepressants Revenue Market Share by Company in 2023
Figure 30. Global Antidepressants Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Antidepressants Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Antidepressants Sales 2019-2024 (K Units)
Figure 33. Americas Antidepressants Revenue 2019-2024 ($ Millions)
Figure 34. APAC Antidepressants Sales 2019-2024 (K Units)
Figure 35. APAC Antidepressants Revenue 2019-2024 ($ Millions)
Figure 36. Europe Antidepressants Sales 2019-2024 (K Units)
Figure 37. Europe Antidepressants Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Antidepressants Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa Antidepressants Revenue 2019-2024 ($ Millions)
Figure 40. Americas Antidepressants Sales Market Share by Country in 2023
Figure 41. Americas Antidepressants Revenue Market Share by Country in 2023
Figure 42. Americas Antidepressants Sales Market Share by Type (2019-2024)
Figure 43. Americas Antidepressants Sales Market Share by Application (2019-2024)
Figure 44. United States Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Antidepressants Sales Market Share by Region in 2023
Figure 49. APAC Antidepressants Revenue Market Share by Regions in 2023
Figure 50. APAC Antidepressants Sales Market Share by Type (2019-2024)
Figure 51. APAC Antidepressants Sales Market Share by Application (2019-2024)
Figure 52. China Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Antidepressants Sales Market Share by Country in 2023
Figure 60. Europe Antidepressants Revenue Market Share by Country in 2023
Figure 61. Europe Antidepressants Sales Market Share by Type (2019-2024)
Figure 62. Europe Antidepressants Sales Market Share by Application (2019-2024)
Figure 63. Germany Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Antidepressants Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Antidepressants Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Antidepressants Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Antidepressants Sales Market Share by Application (2019-2024)
Figure 72. Egypt Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Antidepressants Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Antidepressants in 2023
Figure 78. Manufacturing Process Analysis of Antidepressants
Figure 79. Industry Chain Structure of Antidepressants
Figure 80. Channels of Distribution
Figure 81. Global Antidepressants Sales Market Forecast by Region (2025-2030)
Figure 82. Global Antidepressants Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Antidepressants Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Antidepressants Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Antidepressants Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Antidepressants Revenue Market Share Forecast by Application (2025-2030)

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Kavita Mehra

Kavita Mehra

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (09 May, 2026)
  • Notify To Team (09 May, 2026)
  • Report updation (10 May, 2026)
  • Report Quality Check (10 May, 2026)
  • Report Dispatch (11 May, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Antidepressants Market Growth 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.